Frank C. Albers
Avillion (United Kingdom)(GB)
Publications by Year
Research Areas
Asthma and respiratory diseases, Respiratory and Cough-Related Research, Eosinophilic Esophagitis, Chronic Obstructive Pulmonary Disease (COPD) Research, Inhalation and Respiratory Drug Delivery
Most-Cited Works
- → Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial(2017)575 cited
- → Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease(2017)572 cited
- → Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma(2018)293 cited
- → The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA(2017)279 cited
- → Biomarkers for severe eosinophilic asthma(2017)221 cited
- → Acute and chronic systemic corticosteroid–related complications in patients with severe asthma(2015)215 cited
- → Anti–IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison(2018)210 cited
- → Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study(2019)163 cited
- → The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma(2019)157 cited
- → Dose-Response Relationship Between Long-Term Systemic Corticosteroid Use and Related Complications in Patients with Severe Asthma(2016)129 cited